EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin

Cambier S., Sylvester R. J. , Collette L., Gontero P., Brausi M. A. , van Andel G., ...More

EUROPEAN UROLOGY, vol.69, no.1, pp.60-69, 2016 (SCI-Expanded) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 69 Issue: 1
  • Publication Date: 2016
  • Doi Number: 10.1016/j.eururo.2015.06.045
  • Journal Name: EUROPEAN UROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.60-69
  • Keywords: Non-muscle-invasive bladder cancer, Prognostic factors, Recurrence, Progression, Survival, Bacillus Calmette-Guerin, TRANSITIONAL-CELL CARCINOMA, PROGNOSTIC-FACTORS, FOLLOW-UP, TA, T1, IMMUNOTHERAPY, INSTILLATIONS, TABLES, MODEL
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No


Background: There are no prognostic factor publications on stage Ta-T1 non-muscle-invasive bladder cancer (NMIBC) treated with 1-3 yr of maintenance bacillus Calmette-Guerin (BCG).